课题基金 / 基金详情

RECOMBINANT HUMAN GROWTH HORMONE (NUTROPIN) IN CHILDREN POST RENAL TRANSPLANT

RECOMBINANT HUMAN GROWTH HORMONE (NUTROPIN) IN CHILDREN POST RENAL TRANSPLANT
儿童肾移植后的重组人类生长激素(NUTROPIN)
批准号:
6244713
负责人:
JOSEPH T FLYNN
金额:
$2.22万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-20 至 1997-11-30

项目摘要

项目成果

JOSEPH T FLYNN的其他基金

相关文献

中文摘要
翻译
肾功能衰竭(CRF)儿童发育不良可能无法纠正 进行肾移植。重组人生长激素(RhGH), 现在用于治疗CRF儿童移植前的,可能是 移植后也很有效,但可能会造成独特的问题 比如慢性排斥。本研究旨在研究其疗效。 在这一人群中,重组人生长激素治疗的安全性。
英文摘要
Poor growth in children with renal failure (CRF) may not be corrected with renal transplantation. Recombinant human growth hormone (rhGH), now in use to treat children with CRF pre-transplantation, may be effective post-transplantation as well, but may cause unique problems such as chronic rejection. This study is intended to study the efficacy and safety of rhGH treatment in this population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NUTROPIN RECOMBINANT HUMAN GROWTH HORMONE IN POST RENAL TRANSPLANTATION
VITAMIN E IN TREATMENT OF IGA NEPHROPATHY IN CHILDREN
NUTROPIN RECOMBINANT HUMAN GROWTH HORMONE IN POST RENAL TRANSPLANTATION
PREDNISONE & FISH OIL SUPPLEMENTS IN CHILDREN & YOUNG ADULTS W/ IGA NEPHROLOGY